Trial reportMedicine2025
Effects of 2 different rehabilitation programs on jumping performance after ACL reconstruction: A randomized controlled trial.
Trial report in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Functional rehabilitation strategies for enhancing neuromuscular control after ACL reconstruction: A systematic review.Hong Kong physiotherapy journal : official publication of the Hong Kong Physiotherapy Association Limited = Wu li chih liao · 2026Article
- Emerging Technologies in Sports-Related Knee Injuries and Rehabilitation: A Systematic Review.Cureus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundObjective criteria-based rehabilitation (OCBR) has shown potential in improving muscle strength and reducing knee laxity following anterior cruciate ligament reconstruction (ACLR). Limited evidence exists regarding its effectiveness in restoring functional jumping capacity. The objective of this study was to compare the effects of 2 rehabilitation programs on vertical and horizontal jumping performance at 3 to 6 and 12 months after ACLR.
methodsA longitudinal clinical double-blind randomized controlled trial was carried out. Forty recreational athletes (30 males, 10 females; age: 24 ± 6.9 years; height: 176.55 ± 6.6 cm; weight: 73.58 ± 12.3 kg), Tegner activity level of 7, were recruited. Participants were randomly assigned to either the OCBR or usual care rehabilitation (UCR) programs following primary ACLR. Vertical and horizontal jumping performance was assessed at 3-, 6-, and 12-month post-surgery.
resultsOCBR group showed significantly better performance 6 months postoperatively among ACLR limbs in both vertical (unilateral drop jump 14.5 ± 3.6 vs 11.6 ± 4.6 cm, P < .05, ES = 0.7; bilateral drop jump 30.4 ± 6.4 vs 24.3 ± 6.0, P < .05, ES = 0.9) and horizontal jumping tasks (unilateral triple hop for distance 422.3 ± 52.3 vs 340.4 ± 53.1 cm, P < .05, ES = 1.5; unilateral cross over hop for distance 355.4 ± 52.0 vs309.7 ± 70.4 cm, P < .05, ES = 1.2). These differences remain consistent also at 12-months post-surgery compared to the UCR group between their operated limbs for vertical (unilateral drop jump 15.8 ± 3.2 vs 12.2 ± 3.3 cm, P < .05, ES = 1.1; bilateral drop jump 30.3 ± 4.9 vs 25.2 ± 6.5, P < .05, ES = 0.9) and horizontal maneuvers (unilateral triple hop for distance 452.1 ± 54.9 vs 385.0 51.9 cm, P < .05, ES = 1.6; unilateral cross over hop for distance 385.6 69.6 vs 285.1 60.3 70.4 cm, P < .05, ES = 1.5).
conclusionThe OCBR program led to superior functional performance outcomes at 6- and 12-months following ACL surgery, highlighting its potential as an effective rehabilitation strategy.Implementing an OCBR program post-ACL reconstruction improves functional performance in jumping tasks at 6 and 12 months compared with UCR rehabilitation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.